> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Clinical Investigator Disclosures
- URL: https://www.fdaweb.com/info-collection-on-clinical-investigator-disclosures/
- Published: 2022-03-29T12:00:00.000Z
- Updated: 2026-09-14T17:38:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151468

*Federal Register* notice: FDA has submitted to OMB an information collection extension entitled “Financial Disclosure by Clinical Investigators” (OMB Control Number 0910-0396). FDA’s regulations require that applicants submitting an application that relies on clinical studies must submit a complete list of clinical investigators who participated in a covered clinical study, and must either certify to the absence of certain financial arrangements with clinical investigators (Form FDA 3454) or disclose to FDA the nature of those arrangements and the steps taken by the applicant or sponsor to minimize the potential for bias (Form FDA 3455). To view the notice, click [here](https://public-inspection.federalregister.gov/2022-06661.pdf?ref=fdaweb.com).